I came to London to report about higher education but I stayed for the austerity.

Raging Bull Markets: How Young Men’s Hormones Unsettle Finance

bloomberg.com — Want to calm financial markets? Add more women and older people to the young men on trading desks. That's one recommendation from research into the role of hormones in provoking risky behavior in financial decisions.

Glaxo Paid Doctors $15 Million Before Pledge to End Fees in 2016

bloomberg.com — GlaxoSmithKline Plc paid U.S. doctors about $15 million in 2014 to promote and learn about its products, showing little change from the previous year even as it works to end most payments to physicians by 2016. The total includes consulting and speaking fees, as well as meals and travel for thousands of doctors.

For Nobel Prize Winner Betzig, Quitting Let Best Ideas Prosper

bloomberg.com — Oct. 8 (Bloomberg) -- Want to win a Nobel Prize? Quit your day job. That worked for Eric Betzig, at least, who is part of a trio of scientists recognized with the Nobel in chemistry today for devising ways for microscopes to look into the molecular hearts of living cells.

Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A

bloomberg.com — Amid a frenzy of biotechnology acquisitions, a clutch of companies working on a revolutionary cancer treatment have yet to be snatched up. That may be only a matter of time. Juno Therapeutics Inc., Kite Pharma Inc., Bluebird Bio Inc. and Cellectis SA are among firms working on CAR T, a gene therapy that supercharges the immune system.

Chicago Economist’s ‘Crazy Idea’ Wins Ken Griffin’s Backing

bloomberg.com — Feb. 23 (Bloomberg) -- John List, a University of Chicago economics professor, strides through the Griffin Early Childhood Center chatting with teachers, complimenting girls on their braids and hollering out the window. He acts like it's his school, and in many ways, it is.

AstraZeneca’s Chief Medical Officer to Depart After Three Years

bloomberg.com — Briggs Morrison, who heads late-stage research and development for AstraZeneca Plc, is leaving after three years at the U.K.'s second-biggest drugmaker. Morrison is departing for "other opportunities" later this month, said Ayesha Bharmal, an AstraZeneca spokeswoman. She declined to say where he is going. Morrison, who joined the company from Pfizer Inc.

Glaxo Investigator Humphrey Released Early From Chinese Prison

bloomberg.com — Peter Humphrey, a British private investigator who worked for GlaxoSmithKline Plc, was released from prison in China following his conviction last year for illegally obtaining information about Chinese citizens. Humphrey was tried in August and sentenced to 2 1/2 years in jail. He was released early for health reasons, according to the Financial Times.

AstraZeneca’s Soriot Open to Buying Immune-Therapy Company

bloomberg.com — AstraZeneca Plc would consider acquiring a developer of a new type of cancer therapy aimed at supercharging the body's immune response, Chief Executive Officer Pascal Soriot said.

AstraZeneca Nearing Decision on Suicide-Linked Drug, CEO Says

bloomberg.com — AstraZeneca Plc will decide in a "few weeks" whether to pursue independently a drug for psoriasis after its partner dropped out of the project, said Pascal Soriot, chief executive officer of the U.K. drug company. Amgen Inc. terminated the development deal on May 22 after patients showed signs of considering suicide, which could lead to regulators requiring a warning on the drug's label.

Competition Over Deadly Ovarian Cancer Heats Up With Clovis Data

bloomberg.com — Clovis Oncology Inc.'s experimental drug shrank tumors in 82 percent of women with a certain type of deadly ovarian cancer, results that offer new promise for patients and promise to heat up the rivalry between the small Colorado biotech and U.K. drug giant AstraZeneca Plc.
More Articles →
Jul 02, 2015

RT @winnieokelley: Yet another reason Wall Street needs more women: young males promote risky behavior in markets. bloom.bg/1HzEE57

Jul 02, 2015

Raging Bull Markets: How hormones in young traders destabilize financial markets @business bloomberg.com/news/articles/…

Jul 02, 2015

RT @JMorganTHE: "Ludicrous" and "crazy" to include overseas students in net migrant count, says Cambridge VC Leszek Borysiewicz timeshighereducation.co.uk/news/uk-univer…

Jul 02, 2015

Researcher neglects to disclose $138K from $CELG in paper touting benefits of its cancer drug, via @DoniBloomfield bloomberg.com/news/articles/…

Jul 01, 2015

RT @thecrimson: As #Harvard faces increased regulatory pressure, the influence of its internal legal apparatus grows. ow.ly/P2sIY

Jul 01, 2015

Saudi prince says he will give away $32B fortune to causes that include women's right. Hmmmmmm. reuters.com/article/2015/0…

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.

Share This Profile